Samsung Biologics-2021 earnings
Samsung Biologics 2021 net profit up 63.3 pct to 393.6 bln won
SEOUL, Jan. 24 (Yonhap) -- Samsung Biologics Co. on Monday reported its 2021 net profit of 393.6 billion won (US$329.1 million), up 63.3 percent from a year earlier.
The company said in a regulatory filing that operating income for the year rose 83.5 percent on-year to 537.3 billion won. Annual revenue increased 34.6 percent to 1.56 trillion won.
(END)
(C) Yonhap News Agency. All Rights Reserved
